NEW YORK (GenomeWeb) – System Biosciences said today that Qiagen has signed a non-exclusive, worldwide license for SBI's ExoQuick exosome isolation technology for research use.

Qiagen intends to use the technology in its precipitation-based miRcury Exosome Kits, complementing its spin column-based exoEasy and exoRNeasy products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.